Zydus launches Ujvira, breakthrough in breast cancer treatment

New Delhi, May 24 (IANS) Zydus Cadila launched Trastuzumab Emtansine, the first Antibody Drug Conjugate (ADC) biosimilar and a highly effective drug for treating both Early and Advanced HER2 positive...

Become a proud member of 1947.com to access this content.